Efiglin-M 500mg/20mg Tablet ER
Images are for reference. Actual packaging may vary.
Metformin (500mg) + Teneligliptin (20mg)
1 units • Other
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
+1 more active ingredient
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Teneligliptin inhibits DPP-4, increasing incretin levels and enhancing insulin secretion.
Medical applications
Efiglin-M 500mg/20mg Tablet ER is a combination medication used to manage type 2 diabetes mellitus. It contains Metformin 500mg, which helps lower glucose production in the liver and improves the body's sensitivity to insulin, and Teneligliptin 20mg, which enhances the release of insulin and reduces glucose levels after meals. The extended-release formulation ensures gradual and consistent release of the medication for improved blood sugar control throughout the day.
This combination helps maintain stable blood glucose levels and reduces the risk of diabetes-related complications when used alongside proper diet and exercise. Efiglin-M Tablet ER supports effective long-term diabetes management under medical supervision.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Efiglin-M 500mg/20mg Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Efiglin-M 500mg/20mg Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Efiglin-M 500mg/20mg Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Efiglin-M 500mg/20mg Tablet ER may be needed. Please consult your doctor. Use of Efiglin-M 500mg/20mg Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
It is not known whether Efiglin-M 500mg/20mg Tablet ER alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Efiglin-M 500mg/20mg Tablet ER is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
0 reviews for Efiglin-M 500mg/20mg Tablet ER






